- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 54.79M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $8.66M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $8.69M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.11M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.33M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.74M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.41M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $17.29M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $19.17M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $21.69M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $23.89M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $25.14M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $27.35M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 50.6M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.16M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $4.31M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.81M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.03 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $3.98M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.43M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$173.91K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $3.8M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $11.71M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $15.52M |
| Capex | Q1 2025 · Feb 14, 2024 | $356.22K |